Sana Biotechnology: High-Risk High-Reward With Breakthrough UP421
Sana revolutionizes treatments for diabetes, cancer, and autoimmune diseases. SANA has high cash burn and dilution risks. See ...
Stocktwits on MSN3d
Mineralys, Sana, Aeon: These 3 Biotech Stocks Saw The Sharpest Retail Interest Spike In Q1
Radnor, Pennsylvania-based Mineralys is a clinical-stage biopharmaceutical company developing treatments for hypertension, ...
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Sana Biotechnology, Inc. (SANA) Shareholders
NEW YORK, NY / ACCESS Newswire / April 3, 2025 / If you suffered a loss on your Sana Biotechnology, Inc. (NASDAQ:SANA) investment and want to ...
Sana Biotechnology upgraded at Citizens despite Q4-led selloff
Sana Biotechnology ( NASDAQ: SANA) was upgraded to Market Outperform from Market Perform at Citizens as the research broker believes the company's stock is undervalued, despite its Q4 results leading ...